Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
26,968,911
-
Shares change
-
-195,410
-
Total reported value, excl. options
-
$153,149,145
-
Value change
-
-$533,008
-
Put/Call ratio
-
153%
-
Number of buys
-
67
-
Number of sells
-
-47
-
Price
-
$5.68
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q3 2024
175 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q3 2024.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26,968,911 shares
.
Largest 10 shareholders include BlackRock, Inc. (6,740,696 shares), VANGUARD GROUP INC (4,740,171 shares), STATE STREET CORP (3,065,947 shares), GEODE CAPITAL MANAGEMENT, LLC (1,883,199 shares), NWAM LLC (910,476 shares), TWO SIGMA INVESTMENTS, LP (830,624 shares), MORGAN STANLEY (718,555 shares), NORTHERN TRUST CORP (695,963 shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (665,976 shares), and GOLDMAN SACHS GROUP INC (662,102 shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.